Dementia Patients and Carers set NICE a challenge
Mar 31, 2005 - 9:15:00 PM
|
|
|
The difference in my life was outstanding. I was given my life back, albeit changed, from sitting zombie like all day I started to be glad to wake up. I saw things in colour again, I could make conversation with my family, I could now choose for myself the right clothes to wear. Such joy, such simple things, all courtesy of two little Reminyl tablets a day.
|
By Alzheimer's Society, UK,
[RxPG] People with dementia and their carers have set the National Institute of Clinical Excellence (Nice) six challenges as part of the Alzheimers Societys response to draft recommendations on drug treatments for Alzheimers. The Alzheimers Society believes that Nice can meet these new challenges and change its decision to withdraw drug treatments for Alzheimers from the NHS.
The challenges were submitted to Nice on Tuesday 22 March, at the end of its period of public consultation. People with dementia and their carers asked Nice to:
Give the evidence of people with dementia and their carers more weight
Nice guidance should reflect the views of patients and carers and meet their healthcare needs. Thousands of people affected by dementia have taken part in this appraisal and this evidence should be given more weight.
Base any calculation of cost effectiveness on a measure of quality of life that is appropriate for dementia
The model used to determine whether these drugs offer good value for money was based on the wrong assumptions. Drug treatments can improve quality of life for many people with dementia and their carers. The guidance should consider what matters most to people with dementia and their carers.
Recognise the benefits that the drugs bring for unpaid carers
Most dementia care is provided by unpaid family and friends. The model does not include any benefits that these drug treatments bring for carers. Carers place a high value on the benefits that the drugs bring for both themselves and the person that they care for both need to be included.
Take into account accurate costs of dementia care
The model is based on costs that are too low, for example the cost of full time care is set at £355 a week. This results in a substantial bias in the final calculation of cost effectiveness. The full spectrum of care, including NHS continuing care, should be taken into account when calculating costs.
Ensure that the model reflects clinical practice
The model assumes that everyone who starts treatment remains on it. In fact only half of the patients who start treatment benefit from it and those who do not benefit stop taking the drugs. Only the costs of those who continue on drug treatment should be used to determine whether they are effective.
Be transparent about how the final costs have been calculated
From the information made publicly available it is impossible to tell how Nice have come to their final costing. This information should be transparent and publicly available.
Neil Hunt, chief executive of the Alzheimers Society said, Nice has had the biggest ever response to one of its consultations from members of the general public. This clearly shows the strength of feeling about why drug treatments that work for people with dementia should be available on the NHS. People with a diagnosis of Alzheimers wrote to Nice without drug treatments, this would not have been possible.
Our six challenges, represent the views of people with dementia and their carers. If Nice meets these challenges, we are convinced that it will change its guidance to reflect the reality of the people whose lives have been affected by dementia.
Representatives from the Alzheimers Society met with Health Secretary Dr John Reid to discuss the Department of Healths submission to Nice, and to ensure that the voices of people with dementia and their carers are heard in this debate.
The Alzheimers Societys submission is available on request. Interviews with people with dementia and their carers can also be arranged.
The difference in my life was outstanding. I was given my life back, albeit changed, from sitting zombie like all day I started to be glad to wake up. I saw things in colour again, I could make conversation with my family, I could now choose for myself the right clothes to wear. Such joy, such simple things, all courtesy of two little Reminyl tablets a day.
Mum is on Aricept and Ebixa her memory is very poor now but she is happy, laughs, jokes, does crossword puzzles. She is content and knows she is loved
She is funny, mischievous, and has an interest in life. I didnt expect this at all after 5 ½ years.
All of the costs of my mothers care, both at home, with private carer support in addition to family, and subsequently within the care home, have been met by the family. Over ten years this is a significant sum of money for which no NHS support has been forthcoming. This situation is the norm and the debate about the cost to the NHS of medication should be assessed in this light. One cannot help but wonder if the NHS were paying for the true cost of the care of Alzheimers sufferers, as opposed to the families of sufferers, the calculation of cost benefit when viewed against the enormous costs of such care would not be different.
Advertise in this space for $10 per month.
Contact us today.
|
 |
|
Subscribe to UK Newsletter
|
|
|
|
Additional information about the news article
|
* The Alzheimer's Society is the UK's leading care and research charity for people with dementia and their carers.
* The Alzheimer's Society is the Medical Journalists Association Medical Charity of the Year. The Alzheimer's Society is the first organisation to win this award.
* Over 750,000 people in the UK have dementia. More than half have Alzheimer's disease.
* Dementia affects one in 20 people over the age of 65 and one in five over the age of 80.
* There are 18,500 people in the UK under the age of 65 with dementia.
* For information and advice on Alzheimer's disease or other forms of dementia call the Alzheimer's Society national helpline on 0845 300 0336.
* Our website address is: www.alzheimers.org.uk
|
|
Feedback
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
|
Top of Page
|
